S01 Clinical Management of Residual/Recurrent Differentiated Thyroid Cancer

Program: Symposia
Saturday, June 15, 2013: 9:15 AM-10:45 AM
Hall D (Moscone Center)
Supported by Genzyme, a Sanofi company
Chair:
Rebecca Leboeuf, MD
9:15 AM
Robert C Smallridge, MD, Endo Div, Mayo Clinic Jacksonville, Jacksonville, FL
9:45 AM
Julie Ann Sosa, MD FACS, Surgery, Duke University, Durham, NC
10:15 AM
Stephanie Anne Fish, MD, Dept of Endocrinology, Memorial Sloan-Kettering Cancer, New York, NY
See more of: Symposia